MemoApp

Alzheimer's Disease and Dementia Home Care Technology

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2020 by Rony Epstein, MemoApp operates with 1–10 employees. The company has received funding across one disclosed round. In September 2020, MemoApp secured a grant from JDC-Israel Eshel to develop its home care technology for Alzheimer's and dementia patients.

Business overview

MemoApp develops a hands-free smart screen designed for home care, specifically targeting individuals with Alzheimer's disease, dementia, and other aging-related memory challenges. The core technology provides a continuous and personalized daily information display, controlled by a caregiver, to maintain active reminder routines. Serving the health tech and life sciences sector, MemoApp's solution aims to foster active aging and independent functioning, enhancing self-confidence and reducing feelings of loneliness, stress, and anxiety for users and their families.

Company Intelligence Q&A

What is MemoApp's primary focus?
MemoApp focuses on developing home care technology for individuals with Alzheimer's disease and dementia, aiming to restore confidence and independence through smart screen solutions.
Who founded MemoApp?
MemoApp was founded by Rony Epstein, who also serves as the Director of Innovation Development.
When was MemoApp founded?
MemoApp was founded in January 2020.
What type of product does MemoApp offer?
MemoApp offers a hands-free home care smart screen that displays continuous and personalized daily information, controlled by a caregiver, to assist users with memory decrease.
Has MemoApp received any grants?
In September 2020, MemoApp secured a grant from JDC-Israel Eshel to support its home care technology development.